Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
Concentra’s $529 Million Initial Public Offering
Ardent Health’s $192 Million IPO
Sidley Austin represented Ardent Health Partners, Inc. in the offering, and Latham & Walkins represented the underwriters. Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC...
Warburg Pincus’ US$1 Billion Investment in Everise
Latham & Watkins advised Warburg Pincus; Kirkland & Ellis acted for Everise. Warburg Pincus, a leading global growth investor, completed a US$1 billion investment in Everise, a leading...
Omada Health’s $80 Million Growth Financing
Latham & Watkins advises Omada Health on growth financing. Omada Health, Inc., a virtual-first healthcare provider that implements clinically-validated behavior change protocols for individuals living with...
Health Care Service Corporation’s Acquisition of Trustmark Health Benefits
Foley & Lardner LLP represented Health Care Service Corporation (HCSC) on the deal, while Latham & Watkins LLP represented Trustmark in the transaction. Health Care Service Corporation...
Arcutis Biotherapeutics’ $150 Million Shares Offering
Latham & Watkins advised Arcutis Biotherapeutics, Inc. in the offering, while Cooley represented the underwriters. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has announced the pricing of its underwritten...
Patient Square Capital’s $1.25 Billion Acquisition of Hanger
Kirkland & Ellis, Greenberg Traurig, and Latham & Watkins advised Patient Square Capital, Foley & Lardner advised Hanger, Proskauer Rose advised Ares Capital Management LLC on...
Lindsay Goldberg’s Investment into MMS Holdings
Latham & Watkins represented Lindsay Goldberg in the transaction. MMS Holdings Inc. (MMS), a leading data-focused contract research organization (CRO), has announced that Lindsay Goldberg, a...
TPG Capital’s Majority Investment in Confluent Medical Technologies
Latham & Watkins represented TPG Capital in the transaction. Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has...
Patient Square Capital’s Acquisition of SOC Telemed
Orrick, Herrington & Sutcliffe acted as deal legal counsel to SOC Telemed and DLA Piper acted as healthcare legal counsel to SOC Telemed. Kirkland & Ellis...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
Erasca’s $345 Million Initial Public Offering
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...